Similarly, in a transgenic MJD/SCA3 mouse model [43], the upregulation of CYP46A1 in the cerebellum led to an alleviation of the motor phenotype and neuropathological abnormalities. This evidence concerns the gene CYP46A1 and Spinocerebellar ataxia type 3.